VMAT2 levels correlate with the severity of Parkinsonism; hence, PET imaging of VMAT2 offers a sensitive in vivo method for detecting the early loss of DA nerve terminals in the striatum and may serve as a biomarker of presymptomatic PD. This evidence concerns the gene SLC18A2 and Parkinsonism.